Intravitreal Dexamethasone Implant in Patients Who Did Not Complete Anti-VEGF Loading Dose During the COVID-19 Pandemic: a Retrospective Observational Study.

Vincenzo ScorciaGiuseppe GiannaccareValentina GattiSabrina VaccaroGabriele PiccoliAnnarita VillìMario Damiano ToroAngeli Christy YuClaudio IovinoFrancesca SimonelliAdriano Carnevali

Published in: Ophthalmology and therapy (2021)

Our results seem to suggest that DEX implant can significantly improve both functional and anatomic clinical outcomes in patients who were unable to complete anti-VEGF loading dose during the COVID-19 pandemic.

Keyphrases

vascular endothelial growth factor
endothelial cells
soft tissue
low dose
high dose
optical coherence tomography